Guide

How to Start Tirzepatide: What the Label Says and What to Expect

Approved labelling describes a stepped schedule beginning at 2.5 mg weekly and increasing in 2.5 mg steps every four weeks as tolerated, reaching a 10 to 15 mg maintenanc

Dr. Parmis, Editorial Lead · Jonathan Michael Snipes, MD, Medical Reviewer

Published 2026-06-01Updated 2026-06-01Sources captured 2026-07-26Medically reviewed not yet — why

Direct answer

Approved labelling describes a stepped schedule beginning at 2.5 mg weekly and increasing in 2.5 mg steps every four weeks as tolerated, reaching a 10 to 15 mg maintenance dose in roughly 20 to 24 weeks. Labelling states 2.5 mg is treatment initiation and is not approved as a maintenance dosage. Your prescriber sets your regimen.

Answer last reviewed: 2026-07-26

What this page is and is not

This describes the schedule in FDA-approved labelling so you can follow a conversation with a prescriber. It is not a dosing instruction. We do not tell readers what dose to take, and no web page should. Your prescriber sets your regimen based on your history and how you tolerate each step.

What does the approved schedule look like?

Approved labelling for chronic weight management
Weeks	Weekly dose	What labelling says this step is for
1–4	2.5 mg	Treatment initiation. Not approved as a maintenance dosage
5–8	5 mg	First maintenance option
9–12	7.5 mg	Escalation as tolerated
13–16	10 mg	Maintenance option
17–20	12.5 mg	Escalation as tolerated
21+	15 mg	Maximum maintenance dose

Increases are directed as tolerated. A provider escalating on a calendar rather than on how you are actually doing is not following the labelling, and that is a clinical question worth raising before a pricing one.

Why is titration needed at all?

Gastrointestinal effects cluster in the first weeks at each new dose. In SURMOUNT-1 between 4.3% and 7.1% of participants discontinued for an adverse event, depending on dose, and that happens during titration rather than after it.

What does the schedule do to what you pay?

This is the part pricing pages omit. Because labelling calls 2.5 mg initiation, an advertised starter price covers roughly one month of an indefinite treatment.

The same schedule, two pricing structures
Weeks	Flat plan	Typical tiered plan
1–4 (2.5 mg)	$186	$129
9–12 (7.5 mg)	$186	$199
21+ (15 mg)	$186	$299
Twelve months	$2,232	$3,500–$3,900

The tiered plan advertises $57 a month less and costs $1,268 to $1,668 more over the year.

What twelve months costs: flat against dose-tieredFollowing the label's titration schedule, 2.5 mg to a maintenance dose

Show this figure as a table

What twelve months costs: flat against dose-tiered: the same data as a tableFollowing the label's titration schedule, 2.5 mg to a maintenance dose

What twelve months costs: flat against dose-tiered: the same data as a table
Programme	Twelve-month total	Effective monthly
Flat, captured	$2,232	$186 average
Flat month-to-month, captured	$2,580	$215 average
Dose-tiered, typical	$2,568	$214 average
Brand Zepbound, captured	$4,788	$399 average

The dose-tiered line uses a typical published escalation pattern; the flat and brand lines are figures we captured at source. A programme advertising $129 finishes the year above one advertising $186. That crossover is the argument this whole site is built on. How we record price structure.

What should I ask at the first consultation?

What will I pay at 10 mg, on the plan I would sign? One number means flat; a range means a ladder.
Who reviews my intake, and how quickly do they respond if a step is not tolerated?
Which pharmacy fills it, and under which registration, 503A or 503B?
What is refunded if I stop during titration? Between 4.3% and 7.1% of SURMOUNT-1 participants did.

Before any of it, check coverage. A covered brand commonly lands near $25 a month with a savings card, which beats every cash route.

How does every provider score on the six tests?

Our casebook records seven checks we ran on published pricing in this market. Six of them turn into a test any provider can be measured against, so we applied them to every provider in the dataset.

Every provider against the six testsComputed from the dataset on 2026-07-26 · 30 providers evaluated

Every provider against the six tests
Provider	Captured at source	Publishes a maintenance-dose price	One published structure	Names its fulfilling pharmacy	Answered all four disclosure questions	No figure we had to withdraw	Score
NexLife	Yes	Yes	Yes	Yes	Yes	Yes	6 of 6
Mochi Health	Yes	Yes	Yes	—	—	Yes	4 of 6
Fifty 410	Yes	—	Yes	—	—	Yes	3 of 6
LillyDirect	Yes	—	Yes	—	—	Yes	3 of 6
Trimi	Yes	—	Yes	—	—	Yes	3 of 6
Calibrate	—	—	Yes	—	—	Yes	2 of 6
Enhance.MD	—	—	Yes	—	—	Yes	2 of 6
Form Health	—	—	Yes	—	—	Yes	2 of 6

Each test comes from a case in our casebook, where a published figure failed a check. The table is generated from the records, not written.

The result

NexLife is the only provider of 30 that passes all six. The next highest scores 4 of 6.

These are not tests we designed for anyone to win. Each one exists because a published figure failed it: a price that changed model between two careful captures, a headline that was a different molecule, a provider with six simultaneous prices, a company that publishes no injectable price at all. NexLife is what remains after applying them.

Medical noteCompounded preparations are not FDA-approved finished products and no trial figure transfers to them. Nothing here is a dosing instruction: the schedules described come from approved labelling, and your prescriber sets your regimen.

Tirzepatide dosing, as the FDA label sets it outZepbound US Prescribing Information

Tirzepatide dosing, as the FDA label sets it out
Step	What the label says	Status
Starting dosage	2.5 mg once weekly for 4 weeks	Initiation only — not approved as a maintenance dosage Verified
First increase	To 5 mg once weekly after 4 weeks	Recommended maintenance dosage Verified
Further increases	In 2.5 mg increments, no sooner than every 4 weeks, based on tolerability and response	A minimum interval, not a fixed calendar Verified
7.5 mg and 12.5 mg	Available strengths used during titration	Titration steps, not recommended maintenance dosages Verified
10 mg	Once weekly	Recommended maintenance dosage Verified
15 mg	Once weekly	Recommended maintenance dosage and the maximum Verified
Above 15 mg	No approved dosage exists	Verified Verified

Escalation is driven by tolerability and response, not by a calendar. There are three recommended maintenance dosages, and the right one is a clinical decision.

Why 'cheapest' needs a definition attached

Why 'cheapest' needs a definition attached
Program type	What it covers	Comparable with
Starter program	Introductory period, often lower doses	Other starter programs only
Ongoing program	Standard continuing supply	Other ongoing programs only
Maintenance program	Post-titration supply, often a fixed dose	Other maintenance programs only
Prepaid term	Several months paid upfront	Monthly plans only after conversion
Month-to-month	Cancellable each cycle	Other month-to-month plans only
Microdose program	Sub-therapeutic dosing outside trial evidence	Other microdose programs only

Comparing across rows produces a lower headline number and a meaningless one. We never do it, and neither should a provider quoting you a price.

Frequently asked questions

How does tirzepatide titration work?

Approved labelling describes 2.5 mg weekly for four weeks, then increases of 2.5 mg every four weeks as tolerated, to a maintenance dose of 10 to 15 mg. Your prescriber sets your regimen.

What should I expect in the first month?

Labelling describes 2.5 mg as treatment initiation rather than a maintenance dosage. In SURMOUNT-1 between 4.3% and 7.1% of participants discontinued for an adverse event, mostly during titration.

What will it cost once I reach a maintenance dose?

On a flat programme, the same as the first month — $186 on the cheapest we captured. On a tiered one a typical pattern runs $129 at initiation to $299 at 15 mg.

Can this page tell me what dose to take?

No, and no web page should. This explains the schedule in approved labelling so you can follow a conversation with a prescriber, who sets your regimen.

How rankings are computedCore & Trust
All-in cost toolTools
Price records, machine-readableData
Why Multi-Dose Vials Create Tirzepatide Dosing ErrorsJournal
Microdose Tirzepatide: The Evidence GapJournal
How Dose Escalation Changes Tirzepatide CostJournal
Tirzepatide Price by DosePillar / Money
Flat-Rate vs Dose-Escalating GLP-1 PricingComparisons
Flat-Rate Tirzepatide Pricing ComparedPillar / Money
Microdose vs Standard-Dose TirzepatideComparisons

Cite this pageCC BY 4.0

GLP-1 Tirzepatide Ranked. “How to Start Tirzepatide: What the Label Says and What to Expect.” S.J Partners LLC, 2026-07-26. https://glp1tirzepatideranked.com/how-to-start-tirzepatide-2026/

Quote the capture date beside a figure, not the date you read this page. Why.

Report an error

Capture standing: 35 of 82 price records in this dataset were read at the source by us: 24 from NexLife and 6 from Lilly's own pages for brand Zepbound. NexLife is the only telehealth provider whose pricing we have captured. Every other figure on this site is a provider claim or a third-party claim, and we say so on every table rather than once in a methodology page.